Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 8/20 | 0.44 |
| ▸ | CA1 | P00915 | 5/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | XBP1 | P17861 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4599522 | 0.73 | CYP3A4 (0.37) | CA2ATML3MBTL1MAPK1ALDH1A1 | |
| SCHEMBL6249435 | 0.69 | CA2 (0.63) | CA2CA1GAAXBP1ATM | |
| SCHEMBL6360927 | 0.69 | CA2 (0.54) | CA2CA1GAAXBP1ATM | |
| SCHEMBL2728830 | 0.68 | ALDH1A1 (0.63) | CA2ATML3MBTL1MAPK1ALDH1A1 | |
| SCHEMBL332832 | 0.67 | CA2 (0.66) | CA2CA1GAAXBP1ATM | |
| SCHEMBL11463252 | 0.67 | CA2 (0.66) | CA2CA1GAAXBP1ATM | |
| SCHEMBL9416552 | 0.67 | EIF2AK2 (0.35) | — | |
| SCHEMBL26688534 | 0.67 | CA2 (0.70) | CA2CA1GAAXBP1ATM | |
| SCHEMBL6360929 | 0.67 | GAA (0.47) | CA2CA1GAAXBP1ATM | |
| SCHEMBL23581684 | 0.66 | CA2 (0.63) | CA2CA1GAAXBP1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100448840-C | Brominated esters, methods for their preparation and use thereof as flame retardants | BROMINE COMPOUNDS LTD (IL) | 2009-01-07 | — | — | CN | disclosed |
| CN-1646471-A | Brominated esters, methods for their preparation and use thereof as flame retardants | BROMINE COMPOUNDS LTD (IL) | 2005-07-27 | — | — | CN | disclosed |
| US-20050124829-A1 | Brominated esters, methods for their preparation and use thereof as flame retardants | BROMINE COMPOUNDS LTD. (IL) | 2005-06-09 | — | — | US | disclosed |
| EP-1478615-A1 | BROMINATED ESTERS, METHODS FOR THEIR PREPARATION AND USE THEREOF AS FLAME RETARDANTS | Bromine Compounds Ltd. (IL) | 2004-11-24 | — | — | EP | disclosed |
| WO-2003070685-A1 | BROMINATED ESTERS, METHODS FOR THEIR PREPARATION AND USE THEREOF AS FLAME RETARDANTS | BROMINE COMPOUNDS LTD. (IL) | 2003-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050124829-A1 | Brominated esters, methods for their preparation and use thereof as flame retardants | CYP2F1, POLL, EBP | CA2 2437/4885CA1 2217/4885GAA 3307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.